Welcome to our dedicated page for Healthy Extracts news (Ticker: HYEX), a resource for investors and traders seeking the latest updates and insights on Healthy Extracts stock.
Healthy Extracts Inc. (HYEX) drives innovation in plant-based nutraceuticals through patented formulations and multi-channel distribution. This dedicated news hub provides investors with verified updates on corporate developments, financial milestones, and market strategies.
Find timely reports on earnings announcements, product launches, intellectual property advancements, and strategic partnerships. Our curated collection simplifies tracking the company’s progress in heart health supplements, cognitive support products, and subscription-based wellness solutions.
Stay informed about HYEX’s operational expansions and regulatory milestones through primary-source press releases. Bookmark this page for direct access to the company’s latest developments in the $400B+ global nutraceutical market.
Healthy Extracts (OTCQB:HYEX) reported first-quarter 2024 financial results. Net revenue rose 12% to $689,000, driven by distribution expansion and subscription revenue growth. Gross margin increased to 59.3% from 45.2%, thanks to improved manufacturing efficiency. The company achieved a positive cash flow of $68,000 for the second consecutive quarter.
Net loss was $861,000 or $(0.30) per share, primarily due to interest expenses and stock-based compensation. Excluding non-core costs, the net income was $2,500. Subscription growth was strong, with Amazon 'Subscribe & Save' customers up 81% and direct-to-consumer subscriptions up 28% year-over-year.
The company plans to launch new products in the latter half of 2024, including anti-aging and sugar blocker gel packs. Healthy Extracts aims for continued growth and profitability in upcoming quarters.